NFLPA calls for full investigation of Hurts medical care as NFL defends Eagles staff
The union says it was never told of a league review into how the Eagles handled Jalen Hurts' blood clot, hours after NFL medical officials publicly backed Philadelphia's physicians
Posted
The Jalen Hurts medical case escalated from a team-level controversy into a standoff between the league and its players' union Tuesday, with the NFLPA demanding a full investigation into how the Eagles handled their quarterback's blood clot while NFL officials spent the afternoon defending Philadelphia's physicians.
The NFLPA is not aware of any NFL investigation into the medical care provided to Jalen Hurts. In fact, the league previously informed the union that it did not plan to review the care he received. Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred. Determining the facts is essential to ensuring players receive the highest level of care and protection going forward.
— NFLPA
The union's position is narrow and deliberate: it is not describing an open review, it says the league previously told the union it did not intend to conduct one. That distinction turns the statement into a request rather than a comment on an ongoing process, and it puts the burden on the NFL to either open the investigation the NFLPA is asking for or explain why it will not.
The league's answer, delivered at its owners-meeting press conference, was a defense of the medical chain rather than of any single decision.
Chief medical officer Allen Sills went further across the session, saying that superficial blood clots are not a novel condition and that the league tracks the data on them and shares it with the union, while declining to address Hurts' case directly because of patient-privacy concerns. He also separated medical judgment from competitive pressure, saying no medical decision on a player is affected by the football side. Earlier, NFL executive vice president Jeff Miller had pointed to what he called considerable, uninformed speculation in the previous day's reporting and unfounded criticism of the Eagles' team physicians.
What prompted the scrutiny is a sequence that was unusually public for an injury case.
Hurts has been diagnosed with deep vein thrombosis and blood clots in both lungs and is expected to miss the rest of the season, which is the outcome that converted a Week 5 availability question into a national story about who cleared him and on what basis. The Eagles, who have already ruled him out for the year, now play on without their starting quarterback while the argument about the process continues above them.
The practical question for the league is what a review would actually examine: the ultrasound finding in London, the decision to let Hurts play the following day, or the follow-up testing that ultimately revealed clots in his lungs. The NFLPA did not say what form an investigation would take, and the league did not commit to one Tuesday.